-
EP4363586
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4363586
| EP4363586 - TREATMENT OF DECREASED BONE MINERAL DENSITY WITH WNT FAMILY MEMBER 5B (WNT5B) INHIBITORS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 05.04.2024 Database last updated on 02.09.2024 | |
| Former | The international publication has been made Status updated on 06.01.2023 | ||
| Former | unknown Status updated on 19.08.2022 | Most recent event Tooltip | 31.07.2024 | Amendment by applicant | Applicant(s) | For all designated states Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591 / US | [2024/19] | Inventor(s) | 01 /
BOVIJN, Jonas Tarrytown, New York 10591 / US | 02 /
SOSINA, Olukayode Tarrytown, New York 10591 / US | 03 /
LOTTA, Luca Andrea Tarrytown, New York 10591 / US | 04 /
BARAS, Aris Tarrytown, New York 10591 / US | [2024/19] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstraße 3 81675 München / DE | [2024/19] | Application number, filing date | 22751500.4 | 30.06.2022 | [2024/19] | WO2022US35846 | Priority number, date | US202163218209P | 02.07.2021 Original published format: US 202163218209 P | [2024/19] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2023278787 | Date: | 05.01.2023 | Language: | EN | [2023/01] | Type: | A2 Application without search report | No.: | EP4363586 | Date: | 08.05.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 05.01.2023 takes the place of the publication of the European patent application. | [2024/19] | Search report(s) | International search report - published on: | EP | 23.03.2023 | Classification | IPC: | C12N15/113, A61K31/713, A61P19/10 | [2024/19] | CPC: |
C12N15/113 (EP,IL,KR);
C12N15/1136 (IL,US);
A61K48/00 (KR);
A61K31/7088 (KR);
A61P19/10 (KR);
C12N9/22 (KR);
C12Q1/6827 (KR);
C12Q1/6883 (IL,KR,US);
G01N33/53 (KR);
G01N33/68 (KR);
C12N2310/14 (EP,IL,KR);
C12N2310/20 (EP,IL,KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/19] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | BEHANDLUNG VON VERRINGERTER KNOCHENMINERALDICHTE MIT INHIBITOREN DES MITGLIEDS 5B DER WNT-FAMILIE (WNT5B) | [2024/19] | English: | TREATMENT OF DECREASED BONE MINERAL DENSITY WITH WNT FAMILY MEMBER 5B (WNT5B) INHIBITORS | [2024/19] | French: | TRAITEMENT DE LA BAISSE DE DENSITÉ MINÉRALE OSSEUSE PAR DES INHIBITEURS DE L'ÉLÉMENT 5B DE LA FAMILLE WNT (WNT5B) | [2024/19] | Entry into regional phase | 22.12.2023 | National basic fee paid | 22.12.2023 | Designation fee(s) paid | 22.12.2023 | Examination fee paid | Examination procedure | 22.12.2023 | Examination requested [2024/19] | 22.12.2023 | Date on which the examining division has become responsible | 30.07.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 19.06.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY]US2009047276 (MOON RANDALL T [US], et al); | [XA]WO2017023973 (SAMUMED LLC [US]); |